Results 231 to 240 of about 93,843 (327)

Therapeutic interventions aimed at cccDNA: unveiling mechanisms and evaluating the potency of natural products. [PDF]

Front Cell Infect Microbiol
Hao L, Li S, Hu X.
europepmc   +1 more source

Evaluation of HBsAg and HBeAg seroconversion rates in patients diagnosed with chronic hepatitis B: A 10-year retrospective analysis. [PDF]

Saudi Med J
Toygar Deniz M, Fatih Karaşın M, Asena Doğan Öntaş İ, Akhan S.   +3 more
europepmc   +1 more source

Molecular characteristics of hepatitis B virus among students and pregnant women in Chad. [PDF]

BMC Infect Dis
Debsikréo N, Leye N, Lo G, Dehainsala M, Debsikréo O, Diaw NA, Ba D, Diagne D, Souare A, Diouf ND, Kouadio NKN, Otchere ID, Moussa AM, Toure-Kane NC, Lunel-Fabiani F.   +14 more
europepmc   +1 more source

Molecular analysis of the a determinant of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis

, 1998
Yong Poovorawan, Apiradee Theamboonlers, Voranush Chongsrisawat, Suwimol Sanpavat   +3 more
openalex   +1 more source

Parenteral viral hepatitis among students in Da Nang, Vietnam, and insights into new hepatitis B virus genotype B classification. [PDF]

Sci Rep
Kalinina OV, Lichnaia EV, Bui NTT, Starkova DA, Petrova OA, Tran NT, Vo CV, Dmitriev AV.   +7 more
europepmc   +1 more source

The Management of Chronic Hepatitis B: 2025 Guidelines Update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada. [PDF]

Can Liver J
Clinical Practice Guidelines Committee Chair, Osiowy C, Panel Members, Alvarez F, Coffin CS, Cooper CL, Fung SK, Ko HH, Poulin S, van Gennip J.   +9 more
europepmc   +1 more source

Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study. [PDF]

Virol J
Chang LJ, Hao CQ, Rao GR, Xu LL, Li J, Cheng Y, Zheng LJ, Wu CW, Chen HX, Chen ZR, Lian JQ, Wu SH, Luo LM, Zhang WL, Zhang Y.   +14 more
europepmc   +1 more source

Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis. [PDF]

Hepatol Int
Chen J, Ji D, Jia J, Zhuang H, Zhang X, Wang FS, Zhang W, Dou X, Tanwandee T, Sarin SK, Maiwall R, Kumar M, Goh GB, Ghazinyan H, Chutaputti A, Chen PJ, You H, Yu ML, George J, Omata M, Wang GQ, Lau G, APASL Viral Elimination Taskforce.   +22 more
europepmc   +1 more source

<i>RUNX3</i> Methylation: An Epigenetic Biomarker for Early Liver Damage Induced by Co-Exposure to Aflatoxin B1 and Hepatitis B Virus. [PDF]

Toxics
Mo Y, Lu X, Zheng S, Deng J, Huang S, Hong Y, Xian X, Yijiati A, Yu X, Luo X, Xiao M, Yang X, Routledge MN, Gong Y, He Z.   +14 more
europepmc   +1 more source

Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection. [PDF]

Front Immunol
Shu Y, Li S, Du Y, Zheng X.
europepmc   +1 more source